Corticosteroid-induced mediastinal widening in myasthenia gravis.
Corticosteroid-induced mediastinal widening with simulated focal lymphadenopathy was found in a patient having myasthenia gravis. To my knowledge, this is the first report of such changes occurring in a patient having myasthenia gravis. As the use of corticosteroids in the treatment of myasthenia gravis becomes more common, this association can be expected to occur more often. Reemphasis of this phenomenon should help to avoid unnecessary surgical intervention in these patients.
D006801:Humans; D008068:Lipomatosis / Q000139:chemically induced; D008297:Male; D008477:Mediastinal Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008479:Mediastinal Neoplasms / Q000139:chemically induced; D008482:Mediastinum / Q000000981:diagnostic imaging; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications* / Q000188:drug therapy; D011241:Prednisone / Q000009:adverse effects* / Q000627:therapeutic use; D011859:Radiography
D011241:Prednisone